Which drug stops preterm labor best? new study pits progesterone against nifedipine

NCT ID NCT07649668

Completed Disease control Sponsor: Dr Mudassar Saeed Pansota Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested two common drugs—vaginal progesterone and oral nifedipine—to see which works better at delaying preterm labor in 160 pregnant women aged 18-35 with a single baby. The goal was to prevent delivery within 48 hours or before 37 weeks. Results could help doctors choose the best treatment to reduce early births.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: vaginal progesterone and nifedipine
What this could lead to: If this trial shows one drug works better, it could help doctors choose the best option to delay preterm labor and reduce early births.
What could go wrong: This is a completed Phase 4 trial with 160 participants, but results may not apply to all pregnant women, especially those with complications or multiple pregnancies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRETERM LABOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obstetric Labor, Premature

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRETERM LABOR

Contacts and locations

Locations

Hilal-e-ahmar Hospital

Faisalabad, Punjab Province, 60000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.